Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.SSE: 600613

2024 Semi-annual Report

Aug 31, 2024 · Issued by Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 31, 2024

On 6ix: 6ix.com/news/2024-semi-annual-report-15

2024 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. on 6ix

Earlier from Shanghai Shenqi Pharmaceutical Investment Management

Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business LicenseAug 2, 2024
Announcement on Implementation of Dividend Distribution of 2023Jun 12, 2024
Announcement on Releasing Pledge of Some Shares Early Repurchased by Controlling ShareholderMay 29, 2024
Announcement on Resolutions of 2023 Annual General MeetingMay 21, 2024
1st Quarter Report of 2024May 1, 2024

Later from Shanghai Shenqi Pharmaceutical Investment Management

Announcement on Attending the 2024 Online Collective Reception Day for Investors of Listed Companies in Shanghai Jurisdiction and Semi-annual Report Performance BriefingSep 7, 2024
Announcement on Abnormal Fluctuations in Stock TradingOct 30, 2024
Report for Q3 2024Oct 31, 2024
Announcement on Attending Collective Q3 Report Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2024Nov 8, 2024
Announcement on Shareholding Reduction Plan for Shareholders with Over 5% SharesNov 9, 2024

All Shanghai Shenqi Pharmaceutical Investment Management news releases

Follow Shanghai Shenqi Pharmaceutical Investment Management into a list and get an email when it puts out news.

Follow Shanghai Shenqi Pharmaceutical Investment Management